Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma
Clinical trial NCT02660710 · COMPLETED
Trial details
- NCT number
- NCT02660710
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2021-07-22
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.